Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae
-
By
-
Nusrat J Epsi
-
Josh G Chenoweth
-
Paul W Blair
-
David A Lindholm
-
Anuradha Ganesan
-
Tahaniyat Lalani
-
Alfred Smith
-
Rupal M Mody
-
Milissa U Jones
-
Rhonda E Colombo
-
Christopher J Colombo
-
Christina Schofield
-
Evan C Ewers
-
Derek T Larson
-
Catherine M Berjohn
-
Ryan C Maves
-
Anthony C Fries
-
David Chang
-
Andrew Wyatt
-
Ann I Scher
-
Celia Byrne
-
Jennifer Rusiecki
-
David L Saunders
-
Jeffrey Livezey
-
Allison Malloy
-
Samantha Bazan
-
Carlos Maldonado
-
Margaret Sanchez Edwards
-
Katrin Mende
-
Mark P Simons
-
Robert J O’Connell
-
David R Tribble
-
Brian K Agan
-
Timothy H Burgess
-
Simon D Pollett
-
Stephanie A Richard
-
June 25, 2024
-
0 min
Top Institutions in Infectious Disease
Brief introduction explaining scope and methodology.
-
#1
National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, MD
-
#2
Mayo Clinic
Rochester, MN
-
#3
Johns Hopkins University School of Medicine
Baltimore, MD
-
#4
Massachusetts General Hospital (MGH) - Harvard Medical School
Boston, MA
-
#5
University of California, San Francisco (UCSF)
San Francisco, CA
